These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 1219453
21. [The epidemiological impact of vaccination strategies in the Lazio Region]. Faustini A, Giorgi-Rossi P, Sangalli M, Spadea T, Perucci CA. Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423 [No Abstract] [Full Text] [Related]
22. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation]. Zverev VV, Iuminova NV. Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648 [Abstract] [Full Text] [Related]
23. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps]. Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G. Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598 [Abstract] [Full Text] [Related]
24. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population]. Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G. Przegl Epidemiol; 2003 Mar; 57(2):281-8. PubMed ID: 12910596 [Abstract] [Full Text] [Related]
25. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Peltola H, Karanko V, Kurki T, Hukkanen V, Virtanen M, Penttinen K, Nissinen M, Heinonen OP. Lancet; 1986 Jan 18; 1(8473):137-9. PubMed ID: 2867355 [Abstract] [Full Text] [Related]
26. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases. Böttiger M, Christenson B, Strandell A, Romanus V. Dev Biol Stand; 1986 Jan 18; 65():37-43. PubMed ID: 3556776 [Abstract] [Full Text] [Related]
30. [Rubella, measles, mumps--epidemiologic, occupational medicine significance and efficacy of adult vaccination]. Hofmann F, Sydow B. Offentl Gesundheitswes; 1989 Jun 08; 51(6):299-302. PubMed ID: 2526940 [Abstract] [Full Text] [Related]
31. MMR vaccine--one year on. Walker D. Practitioner; 1990 May 22; 234(1489):550-2. PubMed ID: 2392406 [No Abstract] [Full Text] [Related]
32. [Measles, mumps and rubella vaccination status of school beginners in Munich]. Markuzzi A, Schlipköter U, Weitkunat R, Meyer G. Soz Praventivmed; 1997 May 22; 42(3):133-43. PubMed ID: 9334085 [Abstract] [Full Text] [Related]
33. [Evaluation of a trivalent combined vaccine against measles, parotiditis and rubella]. Randall AG, Leonard JM. Salud Publica Mex; 1971 May 22; 13(3):313-7. PubMed ID: 5164661 [No Abstract] [Full Text] [Related]
34. A second dose of MMR vaccine for children in the United Kingdom. Commun Dis Rep CDR Wkly; 1996 Jul 26; 6(30):259. PubMed ID: 8755703 [No Abstract] [Full Text] [Related]
38. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella. Heath TC, Burgess MA, Forrest JM. Commun Dis Intell; 1998 Aug 06; 22(8):157-8. PubMed ID: 9735550 [No Abstract] [Full Text] [Related]
40. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles. Bart KJ, Orenstein WA, Hinman AR. Dev Biol Stand; 1986 Aug 06; 65():45-52. PubMed ID: 3104117 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]